Phase I/Ib dose-escalation study of avelumab in Chinese patients with advanced solid tumors.
暂无分享,去创建一个
Y. Liu | Wei Wang | Y. Xin | Ying Cheng | H. Pan | Chongrui Xu | K. Chin | Zhen Wang | H. Tu | Yi‐Long Wu | Hua-jun Chen | H. Lou | Dandan Li | Di Zhao | Yan-Qu Gao | Wenping Xu